Gastroretentive delivery of rifampicin: In vitro mucoadhesion and in vivo gamma scintigraphy

International Journal of Pharmaceutics

Volumn 411, Issue 1-2, 2011, Pages 106-112

  Pund, Swati ^a   Joshi, Amita ^a   Vasu, Kamala ^a   Nivsarkar, Manish ^a   Shishoo, Chamanlal ^a  

^a B V PATEL PHARMACEUTICAL EDUCATION AND RESEARCH DEVELOPMENT PERD CENTRE   (India)

Author keywords

Gamma scintigraphy; Gastroretention; Mucoadhesion; Rifampicin; Texture analysis

Indexed keywords

CARBOMER; MICROCRYSTALLINE CELLULOSE; RIFAMPICIN; TECHNETIUM 99M;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG RETENTION; GAMMA SCINTIGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MUCOADHESION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPHERONIZATION;

ADHESIVES; ADULT; ANTIBIOTICS, ANTITUBERCULAR; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FEMALE; GASTRIC MUCOSA; GASTROINTESTINAL TRACT; HUMANS; MALE; RIFAMPIN; SOLUBILITY; TABLETS; YOUNG ADULT;

EID: 79955974599     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.03.048     Document Type: Article

References (38)

1. Anonymous, 2008. Rifampin. Tuberculosis 88, 151-154.
2. Basit, A.W., Newton, J.M., Lacey, L.F., 1999. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose. Pharm. Dev. Technol. 4, 499-505.
3. Borodkin, S., 1991. Ion exchange resin delivery system. In: Tarcha, P.J. (Ed.), Polymers for Controlled Drug Delivery. CRC Press, Florida, pp. 215-229.
4. Chopra, R., Newton, J.M., Alderborn, G., Podczeck, F., 2001. Preparation of pellets of different shape and their characterization. Pharm. Dev. Technol. 6, 495-503.
5. Davis, S.S., Hardy, J.G., Newman, S.P., Wilding, I.R., 1992. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur. J. Nucl. Med. 19, 971-986.
6. Davis, S.S., 2005. Formulation strategies for absorption windows. Drug Discov. Today 10, 249-257. (Pubitemid 40222218)
7. du Toit, L.C., Pillay, V., Danckwerts, M.P., 2006. Tuberculosis chemotherapy-current drug delivery approaches. Respir. Res. 7, 1-18.
8. Dutt, M., Khuller, G.K., 2001. Sustained release of isoniazid from a single injectable dose of poly (dl-lactide-co-glycolide) microparticles as a therapeutic approach towards tuberculosis. Int. J. Antimicrob. Agents 17, 115-122.
9. Edsman, K., Hägerström, H., 2005. Pharmaceutical applications of mucoadhesion for the non-oral routes. J. Pharm. Pharmacol. 57, 3-22.
10. Fransén, N., Björk, E., Edsman, K., 2008. Changes in the mucoadhesion of powder formulations after drug application investigated with a simplified method. J. Pharm. Sci. 97, 3855-3864.
11. Furlanetto, S., Maestrelli, F., Orlandini, S., Mura, P., 2003. Optimization of dissolution test precision for a ketoprofen oral extended-release product. J. Pharm. Biomed. Anal. 32, 159-165.
12. Goto, T., Morishita, M., Kavimandan, N.J., Takayama, K., Peppas, N.A., 2006. Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats. J. Pharm. Sci. 95, 462-469.
13. Hoichman, D., Gromova, L.I., Sela, J., 2004. Gastroretentive controlled-release drugs. Pharm. Chem. J. 38, 621-624.
14. Howard, M.A., Neau, S.H., Marvin, J.S., 2006. PEO and MPEG in high drug load extruded and spheronized beads that are devoid of MCC. Int. J. Pharm. 307, 66-76.
15. Joshi, A., Pund, S., Nivsarkar, M., Vasu, K., Shishoo, C., 2008. Dissolution test for site-specific release isoniazid pellets in USP apparatus 3 (reciprocating cylinder): optimization using response surface methodology. Eur. J. Pharm. Biopharm. 69, 769-775.
16. Khuller, G.K., Pandey, R., 2003. Sustained release drug delivery systems in management of tuberculosis. Indian J. Chest Dis. Allied Sci. 45, 229-230.
17. Kleinebudde, P., 1994. Shrinking and swelling properties of pellets containing micro-crystalline cellulose and low substituted hydroxypropylcellulose. I. Shrinking properties. Int. J. Pharm. 109, 209-219.
18. Koo, O.M.Y.K., Heng, P.W.S., 2001. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization. Chem. Pharm. Bull. 49, 1383-1387.
19. Mariappan, T.T., Singh, S., 2003. Regional gastrointestinal permeability of rifampicin and isoniazid (alone and their combination) in the rat. Int. J. Tuberc. Lung Dis. 7, 797-803.
20. Mortazavi, S.A., Smart, J.D., 1994. An in-vitro method for assessing the duration of mucoadhesion. J. Control. Release 31, 207-212. (Pubitemid 24268167)
21. Murphy, C.S., Pillay, V., Choonara, Y.E., du Toit, L.C., 2009. Gastroretentive drug delivery systems: current developments in novel system design and evaluation. Curr. Drug Deliv. 6, 451-460.
22. Pandey, R., Sharma, S., Khuller, G.K., 2004. Nebulization of liposome encapsulated antitubercular drugs in guinea pigs. Int. J. Antimicrob. Agents 24, 93-94.
23. Park, C.R., Munday, D.L., 2002. Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy. Int. J. Pharm. 237, 215-226.
24. Prabakaran, D., Singh, P., Jaganathan, K.S., Vyas, S.P., 2004. Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs. J. Control. Release 95, 239-248. (Pubitemid 38232673)
25. Podczeck, F., Course, N.J., Newton, J.M., 1999. Determination of the gastric emptying of solid dosage forms using gamma-scintigraphy: a problem of image timing and mathematical analysis. Eur. J. Nucl. Med. 26, 373-378.
26. Pund, S., Joshi, A., Vasu, K., Nivsarkar, M., Shishoo, C., 2010. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets. Int. J. Pharm. 388, 64-72.
27. Rastogi, R., Sultana, Y., Aqil, M., Ali, A., Kumar, S., Chuttani, K., Mishra, A.K., 2007. Alginate microspheres of isoniazid for oral sustained drug delivery. Int. J. Pharm. 334, 71-77.
28. Rubinstein, A., Friend, D.R., 1994. Specific delivery to the gastrointestinal tract. In: Domb, A.J. (Ed.), Polymeric Site-Specific Pharmacotherapy. John Wiley & Sons, Chichester, U.K., pp. 282-283.
29. Shishoo, C.J., Shah, S.A., Rathod, I.S., Savale, S.S., Kotecha, J.S., Shah, P.B., 1999. Stability of rifampicin in dissolution medium in presence of isoniazid. Int. J. Pharm. 190, 109-123.
30. Shishoo, C.J., Shah, S.A., Rathod, I.S., Savale, S.S., Vora, M.J., 2001a. Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation. Int. J. Pharm. 228, 53-67.
31. Shishoo, C.J., Shah, S.A., Rathod, I.S., Savale, S.S., 2001b. Impaired bioavailability of rifampicin from fixed dose combination formulations with isoniazid. Indian J. Pharm. Sci. 63, 443-449.
32. Souto, C., Rodríguez, A., Parajes, S., Martínez-Pacheco, R., 2005. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization. Eur. J. Pharm. Biopharm. 61, 94-99.
33. Streubell, A., Siepmann, J., Bodmeie, R., 2006. Drug delivery to the upper small intestine window using gastroretentive technologies. Curr. Opin. Pharmacol. 6, 501-508.
34. Thanos, C.G., Liu, Z., Goddard, M., Reineke, J., Bailey, N., Cross, M., Burrill, R., Mathiowitz, E., 2003. Enhancing the oral bioavailability of the poorly soluble drug dicumarol with a bioadhesive polymer. J. Pharm. Sci. 92, 1677-1689.
35. Tho, I., Sande, S.A., Kleinebudde, P., 2003. Disintegrating pellets from a water-insoluble pectin derivative produced by extrusion/spheronization. Eur. J. Pharm. Biopharm. 56, 371-380.
36. Vyas, S.P., Kannan, M.E., Jain, S., Mishra, V., Singh, P., 2004. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int. J. Pharm. 269, 37-49.
37. Wilding, I.R., Coupe, A.J., Davis, S.S., 2001. The role of γ-scintigraphy in oral drug delivery. Adv. Drug Deliv. Rev. 46, 103-124.
38. Woodley, J., 2001. Bioadhesion new possibilities for drug administration? Clin. Pharmacokinet. 40, 77-84. (Pubitemid 32242791)